Harlow et al, A laboratory manual: Cold Spring Harbor Laboratory. Chapters 6 and 14, 1988.* |
Bautista et al., Biosci. Biotechnol. Biochem., 62(3):419-423 (1998). |
Das et al., Meth. Enzymol., 233:601-610 (994). |
Davies et al., J. Biological Chem., 262(20):9908-9913 (1987). |
Gutteridge et al., Biochim Biophys Acta, 759:38-41 (1983). |
Halliwell et al., Arch Biochem Biophys, 246(2):501-514 (1986). |
Halliwell et al., Arch Biochem Biophys, 280(1):1-8 (1990). |
Quinlan et al., J. Pharm. Sci., 81:611-614 (1992). |
Röth, Acta Chirugica Hungarcia, 36(1-4):302-305 (1997). |
Stohs, J. Basic & Clin. Physiol. & Pharmacol., 6(3-4):205-228 (1995). |
Ueda et al., Free Radic. Biol. Med., 18:929-933 (1995). |
Vogel et al., Quant. Chem. Anal., pp. 199-203. |
Cobbe, S.M., et al, “The Time of Onset and Severity of Acidosis in Myocardial Ischemia,” J. of Mol. Cell. Card., Academic Press Inc. Limited (London), p. 745-760, (Jan. 12, 1980). |
Reimer, K.A., MD, PH.D., et al, “The Wavefront Phenomenon of Ischemic Cell Death 1. Myocardial Infarct Size vs Duration of Coronary Occulsion in Dogs,” Circulation, Department of Pathology, Duke University Medical Center (Durham, North Carolina), p. 786-793, (Jan. 12, 1977). |
Reimer, K.A., MD, PH.D., et al., “Myocardial Ischemia, Hypoxia, and Infarction,” The Heart Cardiovascular System: Scientific Foundations, Raven (New York), p. 1875-1953, (Jan. 12, 1992). |
Ishikawa, Y., et al, “Reversible Myocardial Ischemic Injury is Not Associated with Increased Creatine Kinase Activity in Plasma,” Clin. Chem., Department of Medicine, University of Kobe (Kobe, Japan), vol. 43 (No. 3), p. 467-475, (Jan. 12, 1997). |
Roberts, R., MD. et al., “Rapid MB CK Subform Assay and the Early Diagnosis of Myocardial Infarction,” Clin. Lab. Med., Departments of Medicine and Cell Biology, Section of Cardiology and the Bugher Foundation Center for Molecular Biology, Baylor College of Medicine (Houston, Texas), vol. 17 (No. 4), p. 669-683, (Dec. 12, 1997). |
Gobel, E.J.A.M, et al., “Long-term Follow-up After Early Intervention with Intravenous Diltiazem or Intravenous Nitroglycerin for Unstable Angina Pectoris,” Eur. Heart J., Department of Cardiology, University Hospital Groningen (Groningen, The Netherlands), p. 1208-1213, (Feb. 12, 1998). |
Pepine, Carl J., MD, et al., “Effects of Treatment on Outcome in Mildly Symptomatic Patients with Ischemia During Daily Life The Atenolol Silent Ischemia Study (ASIST),” Circulation, American Heart Association Inc. (USA), p. 762-768, (Jan. 12, 1994). |
Hedges, Jerris R., MD, et al., “Prospective Assessment of Presenting Serum Markers for Cardiac Risk Stratification,” Acad. Emerg. Med., Hanley & Belfus, Inc. (USA), vol. 3, p. 27-33, (1996). |
Laussac, Jean-Pierre, et al., “Characterization of the Copper(II)—and Nickel(II)—Transport Site of Human Serum Albumin. Studies of Copper (II) and Nickel(II) Binding to Peptide 1-24 of Human Serum Albumin by 13C and 1H NMR Spectroscopy,” Biochem, American Chemical Society (USA), vol. 23, p. 2832-2838, (Jan. 12, 1984). |
Predki, Paule F., et al., “Further Characterization of the N-terminal Copper(II)—and Nickel(II)—Binding Motif of Proteins,” Biochem J., Department of Biochemistry Research, The Hospital for Sick Children (Toronto, Ontario, Canada), vol. 287, p. 211-215, (Jan. 12, 1992). |
Masuoka, James, et al., “Intrinsic Stoichiometric Equilibrium Constants for the Binding of Zinc(II) and Copper(II) to the High Affinity Site of Serum Albumin,” J. Biol. Chem., The American Society for Biochemistry and Molecular Biology, Inc. (USA), vol. 268, p. 21533-21537, (Jan. 12, 1993). |
Sadler, P.J., et al., “Involvement of a Lysine Residue in the N-terminal Ni2+ and Cu2+ Binding Site of Serum Albumins. Comparison with Co2+, Cd2+ and A13+,” Eur. J. Biochem., found at http://search19.proxy.aol.com:8000/post-query/MedLine/hrs1994/23450?albumin+n+terminal (USA), p. 193-200, (Jan. 12, 1994). |
Chan, Bernard, et al., “Site-specific N-terminal Auto-degradation of Human Serum Albumin,” Eur. J. Biochem., Delta Biotechnology Limited (Nottingham, England), vol. 227, p. 524-528, (Jan. 12, 1995). |
McCord, J., PH.D., “Oxygen-derived Free Radicals in Post Ischemic Tissue Injury,” NEJM, Department of Biochemistry, College of Medicine, University of South Alabama (Mobile, Alabama), vol. 312, p. 159-163, (Jan. 12, 1985). |
Kadota, MD, et al., “Decreased Sulfhydryl Groups of Serum Albumin in Coronary Artery Disease,” Japanese Circulation Journal, vol. 55, pp. 937-941, (Oct. 19, 1991). |
Braughler, “Calcium and Lipid Peroxidation,” From Central Nervous System Diseases Research Unit, p. 99 (1987), The Upjohn Company, Kalamazoo, Michigan. |
Witko-Sarsat, “Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Uremia,” Kidney International vol. 49, pp. 1304-1313 (1996), Interantional Society of Nephrology, Paris, France. |
Davies, “Protein Damage and Degradation by Oxygen Radicals,” The Journal of Biological Chemistry vol. 262, No. 20, Issue of Jul. 15, 1987, pp. 9895-9901; 9902-9907; 9914-9920, University of Southern California, Los Angeles, California. |
Keller, “Immunochemical Detection of Oxidized Proteins,” Chem. Res. Toxicol vol. 6, No. 4, pp. 430-433 (1993), Occupational and Environmental Health Program and Division of Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas. |
Halliwell, “Oxygen Radicals and Tissue Injury,” Proceedings of a Brook Lodge Symposium pp. 100-104 (Apr. 1987), Augusta, Michigan. |
Davies, “Oxygen Radicals Stimulate Intracellular Proteolysis and Lipid Peroxidation by Independent Mechanisms in Erythrocytes,” From the Department of Physiology and Biophysics, Harvard Medical School, vol. 262, No. 17, Issue of Jun. 15, 1987, pp. 8220-8225, Boston, Massachusetts. |
“DNA Damage Linked to Risk of Breast Cancer Spread,” found at http://www.pslgroup.com/dg/6c2e.htm. |
Ishimoto, “Role of Oxygen-Derived Free Radicals in Fetal Growth Reardation Induced by Ischemia-Reperfusion in Rats,” found at http://oac3.hsc.uth.tmc.edu/apstracts/1996/heart/September/37lh.html, p. 1 (Sep. 1996), published in APStracts on Sep. 19, 1996. |
Hisashi, “Atp-sensitive k+ channels in Pancreatic, Cardiac, and Vascular Smooth Muscle Cells,” found at http://oac3.hsc.uth.tmc.edu/apstracts/1997/cell/October/291C.html, p. 1 (Oct. 1997), published in APStracts on Oct. 7, 1997. |
Anderson, “Effects of na+k=2cl Cotransport Inhibition on Myocardial NA and CA During Ischemia and Reperfusion,” found at http://www.uth.tmc.edu/apstracts/1995/cell/September/319c.html, p. 1 (Sep. 1995), published in APStracts on Sep. 23, 1995. |
Huang, “Ischemia- and Reperfusion-Sensitive Cardiac Sympathetic Afferents: Influence of Hydrogen Peroxide and Hydroxyl Radicals,” found at http://www.uth.tmc.edu/apst0racts/1995/heart/April/120h.html, p. 1 (Apr. 1995), published in APStracts on Apr. 4, 1995. |
Gomez, “Ruling Out Ischemia Saves Time and Money,” vol. 6(9) pp. 148, 150, found at http://www.medscape.com/CPG/ClinRE . . . c0609.25.gomez.html, pp. 1-2, Clnicians Publishing Group and Williams & Wilkins, (1996). |
Davies, “Intracellular Proteolytic Systems May Function As Secondary Antioxidant Defenses: An Hypothesis,” Journal of Free Radicals in Biology & Medicine vol. 2, pp. 155-161 and 164-169 (1986), Institute for Toxicology and Department of Biochemistry, University of Southern California. |
QLT Phototherapeutics Inc., “Product Brochure: Photofrin” Manufactured by Lederle Parenterals, Inc. (Apr. 1996). |
Chan, “Site-Specific N-terminal Auto-Degradation of Human Serum Albumin,” Eur. J. Biochem. vol. 227, pp. 524-528 (1995), Delta Biotechnology Limited, Nottingham, England. |
Sheat, “Rapid Detection and Initial Characterization of Genetic Variants of Human Serum Albumin,” Clinical Chemistry Reference Journal 37/7, pp. 1221-1224 (1991), Department of Clinical Biochemistry, Christchurch Hospital, Christchurch, New Zealand. |
Predki, “Further Characterization of the N-terminal Copper (II)- and Nickel(II)-Binding Motif of Proteins,” Biochem J. vol. 287, pp. 211-215 (1992), Department of Biochemisrty Research, The Hospital for Sick Children, Toronto, Ontario, Canada. |
“New Market for Excercise-Induced Ischemia,” American Association for Clinical Chemistry, found at http://www.aacc.org/cln/profiles/97profiles/05/diagpro9702.html, (1997). |
Sogami, “Resolution of Human Mercapt- and Nonmercapatalbumin by High-Performance Liquid Chromatography,” Int. J. Peptide Protein Res. vol. 24, pp. 96-102 (1984), Department of Physiology, School of Medicine, Gifu University, Gifu and Technical Development Laboratory, Asahi Chemical Industry Co., Ltd., Yako, Kawasaki-ku, Kawasaki, Japan. |
Hayakawa, “Alteration of Redox State of Human Serum Albumin in Patients Under Anesthesia and Invasive Surgery,” Journal of Chromatography B. vol. 698 pp. 27-33 (1997), Department of Anesthesiology, Gifu University School of Medicine, Gifu, Japan. |
Wysocki, “Peroxide Plasma Level in Patients with Coronary Heart Disease as a Possible Indicator of Ischemia During Exercise Test,” Coronary Artery Disease vol. 4, No. 7 pp. 645-647 (1993), Department of Intensive Therapy, Institute of Internal Medicine, Academy of Medicine, Poznan, Poland. |
Halliwell, “Commentary Albumin-An Important Extracellular Antioxidant?” Biochemical Pharmacology, vol. 37, No. 4, pp. 569-571, (1988), Department of Biochemistry, King's College, London, U.K. |
Tucker, “Involvement of a Lysine Residue in the N-terminal NI2+ and Cu2+ Binding Site of Serum Albumins. Comparison with Co2+, Cd2+ and A13+,” found at http://search19.proxy.aol.com:8000/post-query/MedLine/hrs1994/234580?albumin+n+t p. 1 (1994), Christopher Ingold Laboratories, University of London, England. |
Marx, “Site-specific Modification of Albumin by Free Radicals,” Biochem. J., vol. 236, pp. 397-400 (1985), Department of Hematology, Beilinson Medical Center, Petah Tikva, Israel and Department of Cellular Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel. |
Cotelle et al., J. Inorganic Biochem., 46:7-15 (1992). |
Bar-Or et al., Eur. J. Biochem., 2001, 268:42-47. |
Brennan et al., Clin. Chim. Acta, 1988, 176:179-184. |
Pepine et al., eds., J. Myocard. Isch., 1994, 6(3):8-9. |
Afans'ev, Superoxide Ion: Chemistry and Biological Implications, vol. I, pp. 26-27, 51, 147-148, 168-196, 248-266 (CRC Press, Boca Raton, FL) (1989). |
Afans'ev, Superoxide Ion: Chemistry and Biological Implictions, vol. II, pp. 139 and 187 (CRC Press, Boca Raton, FL) (1989). |
Alberts et al., Mol. Biol. Cell, (2nd ed., Garland Publishing Inc. 1989). |
Boehringer Mannheim Catalog No. 15947. |
Dolovich et al., Br. J Ind Med, 41:51-55 (1984). |
U.S. application Ser. No. 09/165,581, Bar et al., pending. |
U.S. application Ser. No. 09/165,926, Bar et al., pending. |
Fleming and Nixon, Analytical Biochem, 154:691-701 (1986). |
Genest et al., J Am Coll Cardiol, 16:1114-9 (1990). |
Karck et al., J Heart Lung Transplant, 11:979-85 (1992). |
Mangano et al., N Engl J Med, 323:1781-8 (1990). |
Meister & Anderson, Interconversion of Clutathione and Glutathione Disulfide, pp. 733-739. |
“Meta-Binding Groups of Proteins: A. Evidence for Specific Donor Atoms,” Chapter IV, pp. 61-99. |
Nieboer et al., Br. J. Ind. Med., 41:56-63 (1984). |
Odeh, N Eng. J Med, 324(20):1417-1422 (1991). |
Shirakawa et al., Clin Allergy, 18:451-460 (1988). |
Shirakawa et al., Clin Exp Allergy, 22:213-218 (1992). |
Shirakawa et al., Thorax, 45:267-271 (1990). |
Stryker, Biochemistry, pp. 62-64 and 895-897 (3rd ed. 1988). |
“Toxicity and Physicochemical Properties of Metal: Coordination and Chelation,” Ch. 4, pp. 115-122. |
Veien et al., Contact Dermatitis, 5:378-382 (1979). |
Venugopal and Luckey, “Metal Toxicity in Mammals: Chemical Toxicity of Metal and Metalloids,” vol. 2, pp. 283-289 (1978). |
Yoon et al., J Surg Res, 46:163-165 (1989). |